Denise Chow
  Multiple vaccine efforts appear to show promise, although all are still in early stages.
  Massachusetts-based Moderna reported Monday that phase 1 clinical trials show its  vaccine candidate prompted an immune response  in the human body and was safely tolerated among a small group of volunteers.
  Dr. Anthony Fauci, the nation’s top infectious disease expert, said  in an interview with NPR , “Having looked at the data myself, it is really quite promising."
  Read the full story. 
 